retatrutide effects clinical trial VisualAbstract: reduces body weight by 17.5% in patients with obesity Eli Lilly retatrutide Phase 3

Second Natures programme combines MHRA-approved medication with personalised nutrition guidance from registered dietitians and nutritionists

With CoverWell , patients and providers alike can embrace next-generation therapies with confidence, knowing their health, investment, and legal protection are secured .

Mounjaro leads in reducing A1C and aiding weight loss, while Ozempic is approved to address heart complications in patients with Type 2 diabetes and cardiovascular issues

Both can benefit

GLP-1s may also be an option if youre unable to tolerate metformin due to side effects

The Nursing clinics of North America , 25 (1), 247-261